DESVENLAFAXINE MEDIS desvenlafaxine 100mg modified release tablets blister

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
26-11-2017

Toimeaine:

desvenlafaxine, Quantity: 100 mg

Saadav alates:

Medis Pharma Pty Ltd

INN (Rahvusvaheline Nimetus):

Desvenlafaxine

Ravimvorm:

Tablet, modified release

Koostis:

Excipient Ingredients: magnesium stearate; hypromellose; alginic acid; citric acid monohydrate; povidone; purified talc; microcrystalline cellulose; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black

Manustamisviis:

Oral

Ühikuid pakis:

28, 7, 14

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

For the treatment of major depressive disorder, including the preventiton of relapse. Not indicated for paediatric use.

Toote kokkuvõte:

Visual Identification: Dark brown to red colored, diamond shaped, biconvex tablets, debossed with 'Ll90' on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2014-11-26